Sanderling has benefited from Dennis’ expertise and experience in...
Apr 02 0 Comment- Home
- About
- Telemedicine
- Dialysis
- Careers
- Contact
- Patient Help
- Patient Portal
back to physician network
Dr Eric Wallace
Janice Lea
Jason Cobb
James Someren
Anees Quuyumi
Tahshin Masud
Jose Navarette
Jerome S. Tannenbaum, M.D., Ph.D., FACP
Chairman, President, and Chief Executive Officer
Dr. Tannenbaum holds an M.D. from Vanderbilt University School of Medicine and a Ph.D. in Pharmacology from Vanderbilt University School of Graduate Studies. He completed his training in Internal Medicine at the Jewish Hospital of St. Louis and his Nephrology training at Barnes Hospital, both affiliates of Washington University of St. Louis School of Medicine. He is Board Certified in Internal Medicine and Nephrology and is a Fellow of the American College of Physicians (FACP). He was the founder of REN Corporation-USA (formerly NASDAQ: RENL), a publicly traded provider of dialysis services, where he served as President, Chairman and Chief Executive Officer from 1987 to 1993. In 1993, he founded Medical Information Management Systems, Inc. (MIMS), a medical software company and developer of the robust PEARL EMR system. In 1998, Dr. Tannenbaum became Chairman and Chief Executive Officer of National Nephrology Associates, Inc. (NNA), a nationwide dialysis services provider that he co-founded with some of his original management team from REN.
Dr. Tannenbaum left NNA in June 2003 to co-found Diversified Specialty Institutes, Inc. (DSI) with Dr. G. Patrick Maxwell, and certain former members of the NNA, MIMS, and REN management teams. In 2005, Dr. Tannenbaum led the formation and expansion of DSI Renal, Inc. (an affiliate of DSI), a company that operates over 120 dialysis centers across 26 states, and served as its Chairman and Chief Executive Officer. In late 2008, Dr. Tannenbaum left DSI Renal in order to found Sanderling Healthcare, LLC, to commercialize his pre-engineered construction methodology for hospitals and other healthcare facilities.
Contact Dr. Jerome S. Tannenbaum:
jst@sanderlingllc.com
Stanley Crittenden
M.D. - Chief Medical Officer
Dr. Crittenden has joined Sanderling as the Chief Medical Officer. Dr. Crittenden joins Sanderling from Anthem's Diversified Business Group, CareMore and Aspire Health, where he was National Medical Director for Medicare Advantage ESRD C-SNP plans and led initiatives around kidney disease care and served as their enterprise-wide nephrology subject matter expert. Prior to Anthem Dr. Crittenden worked as a corporate medical director in Humana's Healthcare Services Division, where he served as the chairman of the Humana Clinical Practice Guidelines Committee and received the Humana Excellence and Leadership (HEAL) Award from the Office of the Humana Chief Medical Officer. Stanley is a board certified nephrologist who began his a career at Tulane School of Medicine, followed by an Internship and Residency in Internal Medicine at the University of Chicago, a fellowship in Nephrology at Weill Cornell Medical College, and capped by five years on the faculty of Boston University's Renal Division before entering his various roles as a Payor.
Contact Dr. Stanley Crittenden: SCrittenden@Sanderlingllc.com
Rajeev Prasad
M.D. – SVP Telemedicine
Dr. Prasad is a Board Certified nephrologist. Prior to joining Sanderling he founded a succesful nephrology practice in Las Vegas. He served as one of the medical directors and JV partners of several highly successful dialysis units. In addition to his expertise in physician practice models, he has spearheaded and developed In-center dialysis programs, home dialysis programs, and acute care dialysis programs. He has served as medical director for multiple dialysis facilities over the past decade. Dr. Prasad is focused on the Telemedicine physician model, telemedicine expansion, and new business development.
Contact Dr. Rajeev Prasad:rpmed@hotmail.com